Your browser doesn't support javascript.
loading
Safety and efficacy of eculizumab for the prevention of antibody-mediated rejection after deceased-donor kidney transplantation in patients with preformed donor-specific antibodies.
Glotz, Denis; Russ, Graeme; Rostaing, Lionel; Legendre, Christophe; Tufveson, Gunnar; Chadban, Steve; Grinyó, Josep; Mamode, Nizam; Rigotti, Paolo; Couzi, Lionel; Büchler, Matthias; Sandrini, Silvio; Dain, Bradley; Garfield, Mary; Ogawa, Masayo; Richard, Tristan; Marks, William H.
Afiliación
  • Glotz D; Paris Translational Research Center for Organ Transplantation, Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche-S970, Paris, France.
  • Russ G; Department of Nephrology and Organ Transplantation, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Institut National de la Santé et de la Recherche Médicale, Unité U1160, Paris, France.
  • Rostaing L; Central and Northern Adelaide Renal and Transplantation Services, Royal Adelaide Hospital and University of Adelaide, Adelaide, South Australia, Australia.
  • Legendre C; Formerly Department of Nephrology and Organ Transplantation, Rangueil University Hospital Center, Toulouse, France.
  • Tufveson G; Department of Nephrology, Hemodialysis, Apheresis and Transplantation, Grenoble-Alpes University Hospital Center, Avenue du Maquis du Grésivaudan, La Tronche, France.
  • Chadban S; Adult Nephrology Transplantation Service, Hôpital Necker-Enfants Malades, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
  • Grinyó J; Institut National de la Santé et de la Recherche Médicale U1151, Institut Necker-Enfants Malades, Hôpital Necker-Enfants Malades, Paris, France.
  • Mamode N; Section of Transplantation Surgery, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
  • Rigotti P; Department of Renal Medicine, Royal Prince Alfred Hospital, University of Sydney, Sydney, New South Wales, Australia.
  • Couzi L; Department of Nephrology, Hospital Universitari de Bellvitge, University of Barcelona, Barcelona, Spain.
  • Büchler M; Department of Transplant Surgery, Guy's and St Thomas', Evelina London Children's and Great Ormond Street Hospitals NHS Trust, London, UK.
  • Sandrini S; Kidney and Pancreas Transplant Unit, University Hospital of Padua, Padua, Italy.
  • Dain B; UMR CNRS 5164, ImmunoConcEpT, Bordeaux University, Bordeaux, France.
  • Garfield M; Department of Nephrology-Transplantation-Dialysis-Apheresis, CHU, Bordeaux, France.
  • Ogawa M; Department of Nephrology, Tours University Hospital, Tours, France.
  • Richard T; Division of Nephrology, University of Brescia and Spedali Civili General Hospital, Brescia, Italy.
  • Marks WH; Formerly Alexion Pharmaceuticals, Boston, Massachusetts.
Am J Transplant ; 19(10): 2865-2875, 2019 10.
Article en En | MEDLINE | ID: mdl-31012541
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Riñón / Inactivadores del Complemento / Anticuerpos Monoclonales Humanizados / Rechazo de Injerto / Supervivencia de Injerto / Isoanticuerpos / Fallo Renal Crónico Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Transplant Asunto de la revista: TRANSPLANTE Año: 2019 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Riñón / Inactivadores del Complemento / Anticuerpos Monoclonales Humanizados / Rechazo de Injerto / Supervivencia de Injerto / Isoanticuerpos / Fallo Renal Crónico Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Transplant Asunto de la revista: TRANSPLANTE Año: 2019 Tipo del documento: Article País de afiliación: Francia